Vice President, Clinical Research-Infectious Disease

About the role

Vir Biotechnology seeks a Vice President of Clinical Research to set strategy and lead the development of multiple programs across our infectious disease portfolio, including our Hepatitis Delta program currently in Phase III and BLA‑enabling activities. You will lead the planning, design, and oversight of clinical studies from preclinical through Phase IV and commercialization, with immediate responsibility for advancing our Hepatitis Delta program through registration. Working with internal colleagues and external partners, you will inform target and indication selection and shape clinical strategies. You'll partner with research scientists and external experts to refine development plans and stay current with advances in the field. You'll collaborate with Development Operations, Regulatory, Biometrics, and other functions to oversee trial design and execution. You'll thrive in this role if you're a collaborative, scientifically grounded clinical development leader with a hands‑on, team‑oriented approach. You will lead a team of clinical physicians and scientists while serving as a key influencer across the organization. This role is located in our San Francisco headquarters with an expectation of at least 3 days per week in office.

Responsibilities

• Serve as a strategic clinical leader, shaping creative and efficient development strategies for multiple pipeline assets
• Lead clinical research sub‑teams through direct management of MDs and clinical scientists
• Lead regulatory interactions to advance molecules through development and secure global regulatory approvals
• Collaborate with relevant functions to ensure strategic integration of product development plans
• Oversee all major written deliverables (protocols, clinical sections of regulatory submissions, publications, abstracts) and presentation materials
• Collaborate with Research and Translational Development to identify drug targets and disease indications, and shape clinical development plans
• Be accountable for all relevant timelines and deliverables
• Serve as a key spokesperson at external meetings, including regulatory and scientific forums
• WHO YOU ARE AND WHAT YOU BRING
• MD, DO, or PharmD with a strong research background; specialty training in Infectious Diseases preferred
• 8+ years of progressive clinical development experience with a strong record of strategic trial design, late‑stage execution, and cross‑functional leadership
• Proven track record leading registrational trials and marketing applications (NDA/BLA/MAA) through to approval required
• Deep experience in regulatory interactions with global health authorities, including leading filing strategy and submissions
• Current working knowledge of legal, regulatory, and compliance regulations and guidelines; strong understanding of clinical trial design, execution and statistics
• Adaptable and able to effectively lead, collaborate and influence across a complex matrix organization
• Demonstrated leadership in ambiguous situations; able to inspire a team to excel by fostering a climate of energy, excitement and personal accountability
• #LI-AS1
• #LI-Onsite
• WHO WE ARE AND WHAT WE OFFER
• The expected Salary range for this position is $320,000 to $410,000. Actual pay will be determined based on experience, qualifications, geographic location, and other job-related factors.
• Applicants must currently be authorized to work for any employer in the U.S. We are unable to sponsor or take over sponsorship of an employment Visa at this time.
• All employment decisions at Vir Biotechnology are based on legitimate, non-discriminatory business requirem

Benefits

Additional Information

Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clinical-stage portfolio includes programs for chronic hepatitis delta and multiple PRO-XTEN ® dual-masked T-cell engagers across validated targets in solid tumor indications. Vir Biotechnology also has a preclinical portfolio of programs across a range of infectious diseases and oncologic malignancies. Vir Biotechnology has exclusive rights to the universal PRO-XTEN ® masking platform for oncology and infectious disease. PRO-XTEN ® is a trademark of Amunix Pharmaceuticals, Inc., a Sanofi company. We believe the success of our colleagues drives the success of our mission. We are committed to creating a company where everyone feels supported and encouraged to give their best.

Your Match

How well this role fits your profile.

Company Intel

What employees say

Worked at virbiotechnologyinc? Share your experience